RaySearch Laboratories AB (publ)
RSLBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $7,235,505 | $3,210,791 | $1,962,200 | $2,035,747 |
| - Cash | $462,740 | $343,681 | $160,268 | $102,535 |
| + Debt | $471,934 | $529,358 | $555,386 | $561,398 |
| Enterprise Value | $7,244,699 | $3,396,468 | $2,357,318 | $2,494,610 |
| Revenue | $1,192,029 | $1,022,159 | $843,648 | $641,673 |
| % Growth | 16.6% | 21.2% | 31.5% | – |
| Gross Profit | $1,092,537 | $915,581 | $748,657 | $591,276 |
| % Margin | 91.7% | 89.6% | 88.7% | 92.1% |
| EBITDA | $571,230 | $405,929 | $340,847 | $197,362 |
| % Margin | 47.9% | 39.7% | 40.4% | 30.8% |
| Net Income | $203,513 | $81,572 | $23,778 | -$47,315 |
| % Margin | 17.1% | 8% | 2.8% | -7.4% |
| EPS Diluted | 5.94 | 2.38 | 0.69 | -1.38 |
| % Growth | 149.6% | 244.9% | 150% | – |
| Operating Cash Flow | $485,230 | $455,931 | $356,777 | $238,162 |
| Capital Expenditures | -$217,543 | -$209,330 | -$231,501 | -$255,222 |
| Free Cash Flow | $267,687 | $246,601 | $125,276 | -$17,060 |